Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Alpha 1-Antitrypsin deficiency in liver explants in a Mexican cohort: A unique cohort to assess the role of heterozygous genotypes in liver disease.

Clinics and research in hepatology and gastroenterology

Karatas E, Bouchecareilh M.
PMID: 33069636
Clin Res Hepatol Gastroenterol. 2021 May;45(3):101538. doi: 10.1016/j.clinre.2020.09.003. Epub 2020 Oct 14.

No abstract available.

Cite
Karatas E, Bouchecareilh M. Alpha 1-Antitrypsin deficiency in liver explants in a Mexican cohort: A unique cohort to assess the role of heterozygous genotypes in liver disease. Clin Res Hepatol Gastroenterol. 2020;45(3):101538doi: 10.1016/j.clinre.2020.09.003.
Karatas, E., & Bouchecareilh, M. (2021). Alpha 1-Antitrypsin deficiency in liver explants in a Mexican cohort: A unique cohort to assess the role of heterozygous genotypes in liver disease. Clinics and research in hepatology and gastroenterology, 45(3), 101538. https://doi.org/10.1016/j.clinre.2020.09.003
Karatas, E, and Bouchecareilh, M. "Alpha 1-Antitrypsin deficiency in liver explants in a Mexican cohort: A unique cohort to assess the role of heterozygous genotypes in liver disease." Clinics and research in hepatology and gastroenterology vol. 45,3 (2021): 101538. doi: https://doi.org/10.1016/j.clinre.2020.09.003
Karatas E, Bouchecareilh M. Alpha 1-Antitrypsin deficiency in liver explants in a Mexican cohort: A unique cohort to assess the role of heterozygous genotypes in liver disease. Clin Res Hepatol Gastroenterol. 2021 May;45(3):101538. doi: 10.1016/j.clinre.2020.09.003. Epub 2020 Oct 14. PMID: 33069636.
Copy Download .nbib Format: NLM
Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency.

JHEP reports : innovation in hepatology

Karatas E, Raymond AA, Leon C, Dupuy JW, Di-Tommaso S, Senant N, Collardeau-Frachon S, Ruiz M, Lachaux A, Saltel F, Bouchecareilh M.
PMID: 34151245
JHEP Rep. 2021 Apr 24;3(4):100297. doi: 10.1016/j.jhepr.2021.100297. eCollection 2021 Aug.

BACKGROUND & AIMS: A single point mutation in the Z-variant of alpha 1-antitrypsin (Z-AAT) alone can lead to both a protein folding and trafficking defect, preventing its exit from the endoplasmic reticulum (ER), and the formation of aggregates that...

Cite
Karatas E, Raymond AA, Leon C, et al. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency. JHEP Rep. 2021;3(4):100297doi: 10.1016/j.jhepr.2021.100297.
Karatas, E., Raymond, A. A., Leon, C., Dupuy, J. W., Di-Tommaso, S., Senant, N., Collardeau-Frachon, S., Ruiz, M., Lachaux, A., Saltel, F., & Bouchecareilh, M. (2021). Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency. JHEP reports : innovation in hepatology, 3(4), 100297. https://doi.org/10.1016/j.jhepr.2021.100297
Karatas, Esra, et al. "Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency." JHEP reports : innovation in hepatology vol. 3,4 (2021): 100297. doi: https://doi.org/10.1016/j.jhepr.2021.100297
Karatas E, Raymond AA, Leon C, Dupuy JW, Di-Tommaso S, Senant N, Collardeau-Frachon S, Ruiz M, Lachaux A, Saltel F, Bouchecareilh M. Hepatocyte proteomes reveal the role of protein disulfide isomerase 4 in alpha 1-antitrypsin deficiency. JHEP Rep. 2021 Apr 24;3(4):100297. doi: 10.1016/j.jhepr.2021.100297. eCollection 2021 Aug. PMID: 34151245; PMCID: PMC8192868.
Copy Download .nbib Format: NLM
Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.

Molecular oncology

Nguyen TL, Nokin MJ, Terés S, Tomé M, Bodineau C, Galmar O, Pasquet JM, Rousseau B, van Liempd S, Falcon-Perez JM, Richard E, Muzotte E, Rezvani HR, Priault M, Bouchecareilh M, Redonnet-Vernhet I, Calvo J, Uzan B, Pflumio F, Fuentes P, Toribio ML, Khatib AM, Soubeyran P, Murdoch PDS, Durán RV.
PMID: 33314742
Mol Oncol. 2021 May;15(5):1412-1431. doi: 10.1002/1878-0261.12877. Epub 2021 Feb 13.

The cellular receptor Notch1 is a central regulator of T-cell development, and as a consequence, Notch1 pathway appears upregulated in > 65% of the cases of T-cell acute lymphoblastic leukemia (T-ALL). However, strategies targeting Notch1 signaling render only modest...

Cite
Nguyen TL, Nokin MJ, Terés S, et al. Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia. Mol Oncol. 2021;15(5):1412-1431doi: 10.1002/1878-0261.12877.
Nguyen, T. L., Nokin, M. J., Terés, S., Tomé, M., Bodineau, C., Galmar, O., Pasquet, J. M., Rousseau, B., van Liempd, S., Falcon-Perez, J. M., Richard, E., Muzotte, E., Rezvani, H. R., Priault, M., Bouchecareilh, M., Redonnet-Vernhet, I., Calvo, J., Uzan, B., Pflumio, F., Fuentes, P., Toribio, M. L., Khatib, A. M., Soubeyran, P., Murdoch, P. D. S., & Durán, R. V. (2021). Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia. Molecular oncology, 15(5), 1412-1431. https://doi.org/10.1002/1878-0261.12877
Nguyen, Tra Ly, et al. "Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia." Molecular oncology vol. 15,5 (2021): 1412-1431. doi: https://doi.org/10.1002/1878-0261.12877
Nguyen TL, Nokin MJ, Terés S, Tomé M, Bodineau C, Galmar O, Pasquet JM, Rousseau B, van Liempd S, Falcon-Perez JM, Richard E, Muzotte E, Rezvani HR, Priault M, Bouchecareilh M, Redonnet-Vernhet I, Calvo J, Uzan B, Pflumio F, Fuentes P, Toribio ML, Khatib AM, Soubeyran P, Murdoch PDS, Durán RV. Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia. Mol Oncol. 2021 May;15(5):1412-1431. doi: 10.1002/1878-0261.12877. Epub 2021 Feb 13. PMID: 33314742; PMCID: PMC8096784.
Copy Download .nbib Format: NLM
Alpha-1 Antitrypsin Deficiency-Mediated Liver Toxicity: Why Do Some Patients Do Poorly? What Do We Know So Far?.

Chronic obstructive pulmonary diseases (Miami, Fla.)

Bouchecareilh M.
PMID: 32558486
Chronic Obstr Pulm Dis. 2020 Jul;7(3):172-181. doi: 10.15326/jcopdf.7.3.2019.0148.

Alpha-1 antitrypsin deficiency (AATD) is a rare genetic disease caused by mutations in the

Cite
Bouchecareilh M. Alpha-1 Antitrypsin Deficiency-Mediated Liver Toxicity: Why Do Some Patients Do Poorly? What Do We Know So Far?. Chronic Obstr Pulm Dis. 2020;7(3):172-181doi: 10.15326/jcopdf.7.3.2019.0148.
Bouchecareilh, M. (2020). Alpha-1 Antitrypsin Deficiency-Mediated Liver Toxicity: Why Do Some Patients Do Poorly? What Do We Know So Far?. Chronic obstructive pulmonary diseases (Miami, Fla.), 7(3), 172-181. https://doi.org/10.15326/jcopdf.7.3.2019.0148
Bouchecareilh, Marion. "Alpha-1 Antitrypsin Deficiency-Mediated Liver Toxicity: Why Do Some Patients Do Poorly? What Do We Know So Far?." Chronic obstructive pulmonary diseases (Miami, Fla.) vol. 7,3 (2020): 172-181. doi: https://doi.org/10.15326/jcopdf.7.3.2019.0148
Bouchecareilh M. Alpha-1 Antitrypsin Deficiency-Mediated Liver Toxicity: Why Do Some Patients Do Poorly? What Do We Know So Far?. Chronic Obstr Pulm Dis. 2020 Jul;7(3):172-181. doi: 10.15326/jcopdf.7.3.2019.0148. PMID: 32558486; PMCID: PMC7857713.
Copy Download .nbib Format: NLM
Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia.

Molecular oncology

Nguyen TL, Nokin MJ, Terés S, Tomé M, Bodineau C, Galmar O, Pasquet JM, Rousseau B, van Liempd S, Falcon-Perez JM, Richard E, Muzotte E, Rezvani HR, Priault M, Bouchecareilh M, Redonnet-Vernhet I, Calvo J, Uzan B, Pflumio F, Fuentes P, Toribio ML, Khatib AM, Soubeyran P, Murdoch PDS, Durán RV.
PMID: 33314742
Mol Oncol. 2021 May;15(5):1412-1431. doi: 10.1002/1878-0261.12877. Epub 2021 Feb 13.

The cellular receptor Notch1 is a central regulator of T-cell development, and as a consequence, Notch1 pathway appears upregulated in > 65% of the cases of T-cell acute lymphoblastic leukemia (T-ALL). However, strategies targeting Notch1 signaling render only modest...

Cite
Nguyen TL, Nokin MJ, Terés S, et al. Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia. Mol Oncol. 2021;15(5):1412-1431doi: 10.1002/1878-0261.12877.
Nguyen, T. L., Nokin, M. J., Terés, S., Tomé, M., Bodineau, C., Galmar, O., Pasquet, J. M., Rousseau, B., van Liempd, S., Falcon-Perez, J. M., Richard, E., Muzotte, E., Rezvani, H. R., Priault, M., Bouchecareilh, M., Redonnet-Vernhet, I., Calvo, J., Uzan, B., Pflumio, F., Fuentes, P., Toribio, M. L., Khatib, A. M., Soubeyran, P., Murdoch, P. D. S., & Durán, R. V. (2021). Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia. Molecular oncology, 15(5), 1412-1431. https://doi.org/10.1002/1878-0261.12877
Nguyen, Tra Ly, et al. "Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia." Molecular oncology vol. 15,5 (2021): 1412-1431. doi: https://doi.org/10.1002/1878-0261.12877
Nguyen TL, Nokin MJ, Terés S, Tomé M, Bodineau C, Galmar O, Pasquet JM, Rousseau B, van Liempd S, Falcon-Perez JM, Richard E, Muzotte E, Rezvani HR, Priault M, Bouchecareilh M, Redonnet-Vernhet I, Calvo J, Uzan B, Pflumio F, Fuentes P, Toribio ML, Khatib AM, Soubeyran P, Murdoch PDS, Durán RV. Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1-driven acute lymphoblastic leukemia. Mol Oncol. 2021 May;15(5):1412-1431. doi: 10.1002/1878-0261.12877. Epub 2021 Feb 13. PMID: 33314742; PMCID: PMC8096784.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries